Haemonetics Reports 1st Quarter Fiscal 2016 Revenue of $213 Million and Adjusted EPS of $0.35, Reaffirms Full Fiscal Year Guidance
Go back to Haemonetics Reports 1st Quarter Fiscal 2016 Revenue of $213 Million and Adjusted EPS of $0.35, Reaffirms Full Fiscal Year Guidance| HAEMONETICS CORPORATION (NYSE: HAE) | Delayed: 72.78 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $72.78 | 52 Week High | $39.41 | |||
| Open | $72.78 | 52 Week Low | $25.98 | |||
| Day High | $72.78 | P/E | 102.51 | |||
| Day Low | $72.78 | EPS | $0.71 | |||
| Volume | 1,472 | |||||
